SMTL ID : 1h0d.1

Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

hetero-1-1-1-mer

Ligands

8 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 2 residues within 4Å: Chain A: S.14, K.111 2 PLIP interactions: 2 interactions with chain A Water bridges: A:S.14 Salt bridges: A:K.111 SO4.6: 4 residues within 4Å: Chain B: G.54, G.55, R.72, I.74 3 PLIP interactions: 3 interactions with chain B Water bridges: B:G.54, B:R.72, B:R.72 SO4.9: 5 residues within 4Å: Chain C: Q.12, H.13, K.40, N.43, Q.117 5 PLIP interactions: 5 interactions with chain C Hydrogen bonds: C:Q.117 Water bridges: C:Q.12, C:H.114 Salt bridges: C:H.13, C:K.40 SO4.10: 3 residues within 4Å: Chain C: N.49, K.50, R.51 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:K.50, C:R.51 Salt bridges: C:R.51 SO4.11: 2 residues within 4Å: Chain C: H.65, R.66 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:R.66 Salt bridges: C:H.65 SO4.12: 4 residues within 4Å: Chain C: Y.6, L.10, K.50, K.54 4 PLIP interactions: 4 interactions with chain C Hydrogen bonds: C:Y.6, C:Y.6 Salt bridges: C:K.50, C:K.54 SO4.13: 4 residues within 4Å: Chain C: D.15, I.29, R.32, R.33 3 PLIP interactions: 3 interactions with chain C Water bridges: C:R.32 Salt bridges: C:R.32, C:R.33 SO4.14: 4 residues within 4Å: Chain C: K.60, N.61, N.63, H.65 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:N.61 Salt bridges: C:K.60, C:H.65

6 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 1 residues within 4Å: Chain A: S.60 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.60 GOL.3: 3 residues within 4Å: Chain A: S.69, G.70, S.71 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.70, A:S.71 Water bridges: A:S.56, A:S.56, A:G.68 GOL.4: 4 residues within 4Å: Chain A: S.7, P.8, A.9, S.10 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:A.9, A:S.10, A:S.10 GOL.5: 5 residues within 4Å: Chain A: T.168, D.169, D.171 Chain B: V.171, H.172 7 PLIP interactions: 2 interactions with chain B, 5 interactions with chain A Hydrogen bonds: B:V.171, B:H.172 Water bridges: A:D.169, A:D.169, A:D.171, A:T.176, A:S.178 GOL.7: 6 residues within 4Å: Chain A: E.127 Chain B: S.128, V.129, Y.130, V.214, K.216 3 PLIP interactions: 2 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:V.129, B:K.216, A:E.127 GOL.8: 5 residues within 4Å: Chain A: Q.128, S.131, G.133 Chain B: Y.130, K.151 4 PLIP interactions: 2 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:Q.128, B:Y.130, B:Y.130 Water bridges: A:A.134

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chavali, G.B. et al., The Crystal Structure of Human Angiogenin in Complex with an Antitumor Neutralizing Antibody. Structure (2003)

Release Date

2003-06-19

Peptides

ANTIBODY FAB FRAGMENT, LIGHT CHAIN: A
ANTIBODY FAB FRAGMENT, HEAVY CHAIN: B
ANGIOGENIN: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

ANTIBODY FAB FRAGMENT, LIGHT CHAIN

ANTIBODY FAB FRAGMENT, HEAVY CHAIN

ANGIOGENIN

Related Entries With Identical Sequence